Related Experiment Video
Updated: Jul 19, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy
Caroline Godfrey1, Diana Escolar2, Martin Brockington3
1DNA Laboratory, Genetics Centre, Guy's Hospital, London, United Kingdom.
Objective:
Defects in glycosylation of alpha-dystroglycan are associated with several forms of muscular dystrophy, often characterized by congenital onset and severe structural brain involvement, collectively known as dystroglycanopathies. Six causative genes have been identified in these disorders including fukutin. Mutations in fukutin cause Fukuyama congenital muscular dystrophy. This is the second most common form of muscular dystrophy in Japan and is invariably associated with mental retardation and structural brain defects. The aim of this study was to determine the genetic defect in two white families with a dystroglycanopathy.
Methods:
The six genes responsible for dystroglycanopathies were studied in three children with a severe reduction of alpha-dystroglycan in skeletal muscle.
Results:
We identified pathogenic fukutin mutations in these two families. Affected children had normal intelligence and brain structure and shared a limb girdle muscular dystrophy (LGMD) phenotype, had marked elevation of serum creatine kinase, and were all ambulant with remarkable steroid responsiveness.
Interpretation:
Our data suggest that fukutin mutations occur outside Japan and can be associated with much milder phenotypes than Fukuyama congenital muscular dystrophy. These findings significantly expand the spectrum of phenotypes associated with fukutin mutations to include this novel form of limb girdle muscular dystrophy that we propose to name LGMD2L.
Insights
Fukutin gene mutations cause a milder form of limb girdle muscular dystrophy (LGMD2L) outside Japan, expanding the known spectrum of dystroglycanopathies. This discovery offers new insights into muscular dystrophy genetics.
Area of Science:
- Genetics
- Neuromuscular Disorders
- Biochemistry
Background:
- Dystroglycanopathies result from alpha-dystroglycan glycosylation defects, linked to congenital muscular dystrophy.
- Fukutin gene mutations cause Fukuyama congenital muscular dystrophy, prevalent in Japan with severe brain defects and intellectual disability.
Observation:
- Investigated three children with severe alpha-dystroglycan reduction in skeletal muscle.
- Analyzed six known dystroglycanopathy genes.
Findings:
- Identified pathogenic fukutin mutations in two families with a limb girdle muscular dystrophy (LGMD) phenotype.
- Affected individuals exhibited normal intelligence and brain structure, with elevated creatine kinase and steroid responsiveness.
Implications:
- Fukutin mutations are identified outside Japan, presenting milder phenotypes than previously known.
- This expands the phenotypic spectrum of fukutin mutations, defining a novel limb girdle muscular dystrophy, LGMD2L.
More Related Videos
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
10:30Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Sex-linked Disorders
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Mutations
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...